Cargando…
Is the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement?
Several studies have shown that coronary artery bypass graft surgery (CABG) is superior to percutaneous coronary intervention (PCI) in patients with diabetes and multi-vessel disease. Whether this advantage of CABG over PCI is confined to diabetics who require insulin is unknown. We review the publi...
Autores principales: | Lee, Beom Jun, Herbison, Peter, Wong, Cheuk-Kit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981989/ https://www.ncbi.nlm.nih.gov/pubmed/24748887 http://dx.doi.org/10.3969/j.issn.1671-5411.2014.01.009 |
Ejemplares similares
-
Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression
por: Herbison, Peter, et al.
Publicado: (2015) -
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022) -
Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Diabetics with Multivessel Coronary Artery Disease: The Korean Multicenter Revascularization Registry (KORR)
por: Gwon, Hyeon-Cheol, et al.
Publicado: (2005) -
Comparing mortality between coronary artery bypass grafting and percutaneous coronary intervention with drug-eluting stents in elderly with diabetes and multivessel coronary disease
por: Naito, Ryo, et al.
Publicado: (2015) -
Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease
por: Hawranek, Michał, et al.
Publicado: (2018)